Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of prescription opioid misuse and abuse behaviors and risk factors in chronic pain patients using the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ).

Current medical research and opinion·2023
Same author

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study.

JMIR formative research·2022
Same author

Clinical scoring algorithm for the prescription opioid misuse and abuse questionnaire (POMAQ).

Current medical research and opinion·2022
Same author

Non-medical Use of Prescription Stimulants Among College Students: Non-oral Routes of Administration, Risk Factors, Motivations, and Pathways.

Frontiers in psychiatry·2021
Same author

Nonmedical Use of Xtampza<sup>®</sup> ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV<sup>®</sup>).

Journal of pain research·2021
Same author

Construct validity and reproducibility of the Prescription Opioid Misuse And Abuse Questionnaire (POMAQ).

Current medical research and opinion·2020

Related Experiment Video

Updated: Jun 22, 2026

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

Can abuse deterrent formulations make a difference? Expectation and speculation.

Simon H Budman1, Jill M Grimes Serrano, Stephen F Butler

  • 1Inflexxion, Inc., Newton, Massachusetts, USA. simonbudman@inflexxion.com

Harm Reduction Journal
|June 2, 2009
PubMed
Summary
This summary is machine-generated.

Abuse-deterrent formulations (ADFs) aim to reduce prescription opioid misuse. Understanding factors influencing abuse patterns is key to developing effective ADFs that deter alternative routes of administration.

More Related Videos

Novel Apparatus and Method for Drug Reinforcement
07:32

Novel Apparatus and Method for Drug Reinforcement

Published on: August 20, 2010

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic &#946;-Blocker
08:32

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker

Published on: December 18, 2014

Related Experiment Videos

Last Updated: Jun 22, 2026

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

Novel Apparatus and Method for Drug Reinforcement
07:32

Novel Apparatus and Method for Drug Reinforcement

Published on: August 20, 2010

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic &#946;-Blocker
08:32

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker

Published on: December 18, 2014

Area of Science:

  • Pharmacology
  • Addiction Science
  • Drug Development

Background:

  • Prescription opioid misuse presents a significant public health challenge, necessitating a balance between pain management and abuse prevention.
  • Abuse-deterrent formulations (ADFs) are designed to mitigate the misuse of prescription opioids by hindering the extraction of active ingredients for non-prescribed routes of administration.
  • Factors such as pharmacokinetic profiles, formulation characteristics, abuser profiles, addiction progression, and social environment influence opioid abuse patterns.

Purpose of the Study:

  • To examine the multifaceted factors contributing to prescription opioid abuse and the routes of administration employed by abusers.
  • To investigate how the development and implementation of abuse-deterrent formulations (ADFs) may impact existing patterns of prescription opioid misuse.

Main Methods:

  • Literature review and analysis of existing research on prescription opioid abuse.
  • Examination of pharmacokinetic data and formulation properties relevant to abuse potential.
  • Exploration of psychological, social, and environmental factors associated with drug abuse.

Main Results:

  • Multiple factors, including drug pharmacokinetics, formulation design, individual user characteristics, addiction stage, and social context, significantly influence prescription opioid abuse.
  • The specific methods of abuse, such as injection, snorting, or smoking, are often dictated by these influencing factors.
  • ADFs represent a promising strategy to alter these abuse patterns by making it more difficult to extract and misuse the active opioid compound.

Conclusions:

  • A comprehensive understanding of the interplay between drug properties, user behavior, and environmental factors is crucial for effective prescription opioid abuse deterrence.
  • The development of innovative abuse-deterrent formulations holds significant potential to reduce the public health burden associated with prescription opioid misuse.
  • Future research should continue to evaluate the real-world impact of ADFs on abuse trends and explore novel strategies for addiction prevention and treatment.